“National immunobiological company” has started serial production of vaccine against measles, rubella and mumps

Holding “national immunobiological company” rostec state Corporation started the serial production of the first domestic combination vaccine for measles, mumps and rubella in children. Two series of drug released into circulation and ready for shipment.

The combined three-component vaccine Activer received a registration certificate of Ministry of health of Russia in November 2019. A new drug designed for children of 12 months and 6 years.

“We have supplied commercial customers first thousand doses of Russian combined Activer vaccine that protects against three diseases. The use of multicomponent vaccines recommended by the world health organization. It is more efficient and convenient and, ultimately, increases the coverage of immunization, strengthening collective immunity. Until the end of the year we will release to the commercial market of more than 77 thousand doses of a new drug,” – said General Director of “national immunobiological company” Andrey Zagorsky.

The drug is made by NPO “Microgen” the full technological cycle. Capacities of the enterprise allow to provide needs of national health care in a new three-component vaccine.

Currently in Russia for protection against the three diseases under the National immunization calendar used single or measles, rubella and mumps, as well as Depakine mumps-measles.